Ascentage Pharma Group International (AAPG) Operating Leases (2022 - 2024)

Historic Operating Leases for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q4 2024 value amounting to $4.2 million.

  • Ascentage Pharma Group International's Operating Leases rose 3360.73% to $4.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.2 million, marking a year-over-year increase of 3360.73%. This contributed to the annual value of $4.1 million for FY2024, which is 3331.19% up from last year.
  • Latest data reveals that Ascentage Pharma Group International reported Operating Leases of $4.2 million as of Q4 2024, which was up 3360.73% from $3.2 million recorded in Q4 2023.
  • Ascentage Pharma Group International's 5-year Operating Leases high stood at $4.2 million for Q4 2024, and its period low was $2.4 million during Q4 2022.
  • For the 3-year period, Ascentage Pharma Group International's Operating Leases averaged around $3.3 million, with its median value being $3.2 million (2023).
  • In the last 5 years, Ascentage Pharma Group International's Operating Leases soared by 3008.99% in 2023 and then skyrocketed by 3360.73% in 2024.
  • Ascentage Pharma Group International's Operating Leases (Quarter) stood at $2.4 million in 2022, then surged by 30.09% to $3.2 million in 2023, then surged by 33.61% to $4.2 million in 2024.
  • Its Operating Leases was $4.2 million in Q4 2024, compared to $3.2 million in Q4 2023 and $2.4 million in Q4 2022.